Johnson & Johnson plans to settle 99.75% of claims alleging its talc-based baby powder products led to ovarian cancer, the company said May 1.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
J&J to resolve most cancer talc claims for $6.5B
